CBD in Switzerland
Business briefing
Current business and company-related news on the CBD industry
Regulatory briefing
Current legal and regulatory news covering the CBD industry
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market trackers
Up-to-date real-time information and insights on brands, pricing and retail across selected markets
Regulatory trackers
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
Charts and infographics
Highlights of the data and analysis that can be found in our full-length market reports
NEW FORMAT
From February of 2022, subscribers will be able to view and filter individual regulatory alerts per region. If you want to get our alerts compilations, visit our alerts Round-up section.
Alerts
Our legal experts track the evolving regulation around the CBD and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
19th April 2022
Switzerland: The Basel-Stadt canton health department has received the green light from the Federal Office of Public Health to start selling recreational cannabis in pharmacies as part of the first such pilot project to receive official approval. A selected 400 participants will be able to buy various cannabis products, including dried flowers and hashish, at certain pharmacies as part of a study into the effects of sales on consumption behaviour and health. The project will start in late summer 2022 and last for two and a half years.
12th April 2022
Switzerland: The Federal Office of Public Health has confirmed to CBD-Intel that the previously reported decision banning chemical products that contain CBD will only affect products that are covered by the chemicals law; it does not apply medicines, e-cigarettes, therapeutic products or foods containing CBD.
8th April 2022
- Switzerland: The Swiss Confederation has published a decision banning chemical products that contain CBD and are marketed under the requirements of the chemical law, such as CBD-containing fragrance oil. The products will only be allowed to be sold if containing a denaturant that prevents improper oral ingestion. The decision becomes legally binding after six months if no appeals are received. Appeals can be presented within 30 days from 24th March 2022. CBD-Intel has contacted the authorities to clarify the extent of the decision.
7th April 2022
Switzerland: Representatives of the right-wing Swiss People’s Party and the Federal Democratic Union have submitted a motion to ban the sale of recreational cannabis products in pharmacies in the Bern canton. Such sales are intended to begin on a trial basis this autumn as part of a pilot project to establish a sound basis for possible future decisions on regulation. The proposal to block the trial has now to be analysed by the Executive Council of Bern.
